secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001562762-25-000198
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q2 net sales $745.3M (+18.4%); GAAP EPS $1.49, non-GAAP $0.86
----------------------------------------------------------------------------

- Net sales $745.3M, up 18.4% YoY (17.6% constant currency); US Spine grew 5.7% as-reported.
- GAAP net income $202.8M ($1.49 diluted EPS) vs $31.7M ($0.23) a year ago; includes $110.6M bargain purchase gain.
- Non-GAAP diluted EPS $0.86 vs $0.75 (+14.1%); record quarterly non-GAAP EPS.
- Full-year 2025 guidance reaffirmed: revenue $2.80-2.90B; non-GAAP EPS $3.00-3.30.
- Closed Nevro acquisition; net cash from ops $77.9M, non-GAAP free cash flow $31.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000198/0001562762-25-000198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000198/gmed-20250807x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer